Prenatal screening for open neural tube defects and down syndrome: Three decades of progress

Prenatal Diagnosis

Volumn 30, Issue 7, 2010, Pages 619-621

  Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Combined test; Down syndrome; Fetal imaging; Fetal ultrasound; Integrated test; Maternal serum screening; Neural tube defects

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; INHIBIN; INHIBIN A;

AMNION FLUID ANALYSIS; ANENCEPHALUS; COMPARATIVE STUDY; DOWN SYNDROME; ECHOGRAPHY; GEL ELECTROPHORESIS; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; NEURAL TUBE DEFECT; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SPINA BIFIDA; FEMALE; HISTORY; NEURAL TUBE DEFECTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; TRENDS;

ALPHA-FETOPROTEINS; DOWN SYNDROME; FEMALE; HISTORY, 20TH CENTURY; HUMANS; INHIBINS; NEURAL TUBE DEFECTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 77954123100     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2517     Document Type: Review

References (23)

1. Bogart MH, Pandian MR, Jones OW. 1987. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 9: 623-630.
2. Brock DJ, Sutcliffe RG. 1972. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 300: 197-199.
3. Campbell S, Johnstone FD, Holt EM, May P. 1972. Anencephaly: early ultrasonic diagnosis and active management. Lancet 300: 1226-1227.
4. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. 1988. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 95: 330-333.
5. Cuckle HS, Wald NJ, Lindenbaum RH. 1984. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 323: 926-929. (Pubitemid 14136296)
6. Hino M, Koki Y, Nishi S. 1972. Nimpu ketsu naka no alphafetoprotein. Igaku No Ayumi 82: 512-513.
7. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. 1984. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148: 886-894. (Pubitemid 14125705)
8. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency : ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304: 867-869.
9. Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. 1986. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 8498: 72-74. (Pubitemid 16097081)
10. Palomaki GE, Knight GJ, Haddow JE. 1993. Is MoM bashing justified? Am J Hum Genet 53: 777-781.
11. Pandya PP, Snijders RJM, Johnson SP, De Loudes Brizot M, Nicolaides KH. 1995. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102: 957-962.
12. Rottem S, Bronshtein M, Thaler I, Brandes JM. 1989. First trimester transvaginal sonographic diagnosis of fetal anomalies. Lancet i: 444-445. (Pubitemid 19059190)
13. Szabo J, Gellen J. 1990. Nuchal fluid accumulation in Trisomy 21 detected by vaginosonography in first trimester. Lancet 336: 1133. (Pubitemid 20368788)
14. Wald NJ. 1976. The detection of neural tube defects by screening maternal blood. In: Boue A, (ed). Prenatal Diagnosis, vol. 61, Les Colloques de l'Institut National de la Santé et de la Recherche Médicale 227-238.
15. Wald NJ, Brock DJH, Bonnar J. 1974. Prenatal diagnosis of spina bifida and anencephaly by maternal serum alpha-fetoprotein measurement. Lancet 303: 765-767.
16. Wald N, Cuckle H, Boreham J, Stirrat G. 1980. Small biparietal diameter of fetuses with spina bifida: implications for antenatal screening. Br J Obstet Gynaecol 87: 219-221. (Pubitemid 10153702)
17. Wald NJ, Cuckle H, Brock DJH, Peto R, Polani PE, Woodford FP. 1977. Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of the UK Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects. Lancet 309: 1323-1332.
18. Wald NJ, Cuckle HS, Densem JW, et al. 1988a. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 95: 334-341.
19. Wald NJ, Cuckle HS, Densem JW, et al. 1988b. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.
20. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996b. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153. (Pubitemid 26060632)
21. Wald NJ, George L, Smith D, Densem JW, Petterson K. International Prenatal Screening Research Group. 1996a. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
22. Wald NJ, Hackshaw AK. 1997. Combining ultrasound and biochemistry in first trimester screening for Down's syndrome. Prenat Diagn 17: 821-829. (Pubitemid 27384797)
23. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.